MEDIRAZIN 0.5mcg 0.50mcg soft capsules medication leaflet

A11CC03 alfacalcidol • Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues

Alfacalcidol is an active derivative of vitamin D used to treat and prevent disorders related to calcium and phosphorus metabolism. It is indicated for conditions such as renal osteodystrophy, hypoparathyroidism, rickets, and osteomalacia, particularly in patients with chronic kidney disease.

Alfacalcidol works by increasing the absorption of calcium and phosphorus from the intestine and regulating their levels in the blood, thereby supporting bone health and muscle function. It is administered orally or intravenously, depending on the indication.

Side effects may include hypercalcemia (elevated calcium levels in the blood), which can manifest as nausea, vomiting, excessive thirst, frequent urination, or muscle weakness. Regular monitoring of calcium and phosphorus levels is essential during treatment. The medication should be taken as prescribed by a doctor, and patients should avoid calcium or vitamin D supplements without medical advice.

General data about MEDIRAZIN 0.5mcg 0.50mcg

Substance: alfacalcidol

Date of last drug list: 10-04-2026

Commercial code: W67770001

Concentration: 0.50mcg

Pharmaceutical form: soft capsules

Quantity: 30

Product type: generic

Price: 41.71 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: PHARMA PACK HUNGARY KFT. - UNGARIA

Holder: ZENIVA K.S. - REPUBLICA CEHA

Number: 13976/2021/01

Shelf life: 2 years

Pharmaceutical forms available for alfacalcidol

Concentrations available for alfacalcidol

0.25mcg, 0.50mcg, 0.5mcg, 0.5mg, 1.0mcg, 1mcg, 1mcgm, 2mcg/ml

Compensation lists for MEDIRAZIN 0.5mcg 0.50mcg ZENTIVA

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

41.71 RON

20.85 RON

20.86 RON

NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure

Price

Copayment

Patient

41.71 RON

41.71 RON

0.00 RON

NHP 7 (C2) - Endocrine diseases

Price

Copayment

Patient

41.71 RON

41.71 RON

0.00 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

41.71 RON

41.71 RON

0.00 RON